Cardio Papers Flashcards
Van Vark 2012: Aim/ Primary Endpoints
ARBs v ACEi on all-cause and CV mortality
Van Vark 2012: No. Of patients
160,000
Van Vark 2012: Duration
4 year follow up
Van Vark 2012: Study Design
20 trials cv morbidity and mortality trials
Van Vark 2012: Key Findings
observed overall all-cause mortality reduction was almost completely a result of the beneficial effect of the class of ACE inhibitors (10% RR)
Schuttee 2022: Objective
Bring control rates up to 70% by implementing and scaling proven strategies to better BP management
Schuttee 2022: Compare AU control rates to US and Canada
AU: 32%
US: 44% (dropped from 54% in 2014)
CAN: 58%
Schuttee 2022: What are 2 current challenges to the control rate in AU at the moment?
lack of awareness and public health urgency
Schuttee 2022: 6 Specific actions outlined
- wide-scale screening and awareness
- population-based measures (diet/smoking)
- lifestyle approaches (physical activity)
- home monitoring
- clinical training (address clinician inertia)
- education and refresher courses (spcs)
Schuttee 2022: How could a 25% reduction in the current prevalence of hypertension impact the number of lives saved and the Australian economy?
25% reduction = 37k lives saved + return $34b to economy
Roerecke 2019: Study design
systemic review and meta-analysis, 31 studies
Roerecke 2019: Aim
examine AOBP vs offic BP or ABPM
Roerecke 2019: Number of patients
9k
Roerecke 2019: Primary endpoints
ave diff of systolic and diastolic BP between diff types of measuring
Roerecke 2019: Compare AOBP findings to to office and ABPM
AOBP (px alone in quiet place) more accurate than office BP and similar to awake ABPM reading.
